DBV TECHNOLOGIES SA (DBV.DE) Fundamental Analysis & Valuation

FRA:DBV • FR0010417345

Current stock price

3.562 EUR
-0.28 (-7.19%)
Last:

This DBV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DBV.DE Profitability Analysis

1.1 Basic Checks

  • In the past year DBV has reported negative net income.
  • In the past year DBV has reported a negative cash flow from operations.
  • In the past 5 years DBV always reported negative net income.
  • DBV had a negative operating cash flow in each of the past 5 years.
DBV.DE Yearly Net Income VS EBIT VS OCF VS FCFDBV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • DBV has a Return On Assets of -63.05%. This is in the lower half of the industry: DBV underperforms 73.81% of its industry peers.
  • With a Return On Equity value of -87.19%, DBV perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
Industry RankSector Rank
ROA -63.05%
ROE -87.19%
ROIC N/A
ROA(3y)-92.3%
ROA(5y)-76.57%
ROE(3y)-185.25%
ROE(5y)-140.82%
ROIC(3y)N/A
ROIC(5y)N/A
DBV.DE Yearly ROA, ROE, ROICDBV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 86.43%, DBV is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DBV has declined.
  • The Profit Margin and Operating Margin are not available for DBV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-2.4%
DBV.DE Yearly Profit, Operating, Gross MarginsDBV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DBV.DE Health Analysis

2.1 Basic Checks

  • DBV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DBV has been increased compared to 1 year ago.
  • The number of shares outstanding for DBV has been increased compared to 5 years ago.
  • The debt/assets ratio for DBV has been reduced compared to a year ago.
DBV.DE Yearly Shares OutstandingDBV.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DBV.DE Yearly Total Debt VS Total AssetsDBV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 8.32 indicates that DBV is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of DBV (8.32) is better than 83.33% of its industry peers.
  • DBV has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • DBV has a Debt to Equity ratio of 0.03. This is in the better half of the industry: DBV outperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 8.32
ROIC/WACCN/A
WACC8.01%
DBV.DE Yearly LT Debt VS Equity VS FCFDBV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 3.67 indicates that DBV has no problem at all paying its short term obligations.
  • DBV's Current ratio of 3.67 is fine compared to the rest of the industry. DBV outperforms 70.24% of its industry peers.
  • A Quick Ratio of 3.67 indicates that DBV has no problem at all paying its short term obligations.
  • DBV's Quick ratio of 3.67 is fine compared to the rest of the industry. DBV outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.67
DBV.DE Yearly Current Assets VS Current LiabilitesDBV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DBV.DE Growth Analysis

3.1 Past

  • DBV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.66%, which is quite impressive.
  • DBV shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.77%.
  • The Revenue has been growing slightly by 0.50% on average over the past years.
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.84% on average over the next years. This is quite good.
  • Based on estimates for the next years, DBV will show a very strong growth in Revenue. The Revenue will grow by 155.17% on average per year.
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y10.62%
Revenue Next 5Y155.17%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DBV.DE Yearly Revenue VS EstimatesDBV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
DBV.DE Yearly EPS VS EstimatesDBV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DBV.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DBV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DBV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBV.DE Price Earnings VS Forward Price EarningsDBV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBV.DE Per share dataDBV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.4%
EPS Next 3Y10.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DBV.DE Dividend Analysis

5.1 Amount

  • DBV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBV.DE Fundamentals: All Metrics, Ratios and Statistics

DBV TECHNOLOGIES SA

FRA:DBV (4/16/2026, 7:00:00 PM)

3.562

-0.28 (-7.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)07-27
Inst Owners44.96%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap991.48M
Revenue(TTM)5.64M
Net Income(TTM)-147.16M
Analysts80
Price Target3.35 (-5.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-51.04%
Min EPS beat(2)-107.02%
Max EPS beat(2)4.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)161.83%
Min Revenue beat(2)4.35%
Max Revenue beat(2)319.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.18%
PT rev (3m)-16.84%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-182.81%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)-24.64%
Revenue NY rev (3m)-99.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 207.53
P/FCF N/A
P/OCF N/A
P/B 6.93
P/tB 6.93
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.02
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -63.05%
ROE -87.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.43%
FCFM N/A
ROA(3y)-92.3%
ROA(5y)-76.57%
ROE(3y)-185.25%
ROE(5y)-140.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-2.4%
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.15%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.67
Quick Ratio 3.67
Altman-Z 8.32
F-Score5
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.42%
Cap/Sales(5y)20.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue 1Y (TTM)35.77%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%-59.25%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y10.62%
Revenue Next 5Y155.17%
EBIT growth 1Y-26.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.74%
OCF growth 3YN/A
OCF growth 5YN/A

DBV TECHNOLOGIES SA / DBV.DE Fundamental Analysis FAQ

What is the fundamental rating for DBV stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBV.DE.


What is the valuation status for DBV stock?

ChartMill assigns a valuation rating of 0 / 10 to DBV TECHNOLOGIES SA (DBV.DE). This can be considered as Overvalued.


How profitable is DBV TECHNOLOGIES SA (DBV.DE) stock?

DBV TECHNOLOGIES SA (DBV.DE) has a profitability rating of 1 / 10.